| Identification | Back Directory | [Name]
5-[2-[(2S)-2-[1-(4-Bromophenyl)-3-(4-fluorophenyl)-1H-pyrazol-4-yl]-4-oxo-3-oxazolidinyl]ethyl]-1,3-dihydro-2H-benzimidazol-2-one | [CAS]
2137847-77-7 | [Synonyms]
5-[2-[(2S)-2-[1-(4-Bromophenyl)-3-(4-fluorophenyl)-1H-pyrazol-4-yl]-4-oxo-3-oxazolidinyl]ethyl]-1,3-dihydro-2H-benzimidazol-2-one | [Molecular Formula]
C27H21BrFN5O3 | [MOL File]
2137847-77-7.mol | [Molecular Weight]
562.39 |
| Hazard Information | Back Directory | [Uses]
(S)-Canocapavir is the isomer of Canocapavir (HY-147255A). Canocapavir (ZM-H1505R) has orally antiviral activity. Canocapavir is a HBV capsid inhibitor that can be used in the research of Chronic hepatitis B[1]. | [References]
[1] WHO Drug Information, Vol. 36, No. 2, 2022. |
|
|